NEWPORT NEWS, Va., June 18, 2021 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE:HII) announced today that Jason Sutton has been promoted to chief information officer for its Newport News Shipbuilding division, effective June 21. Sutton will be responsible for all aspects of information technology to enable Newport News to establish IT priorities and meet strategic objectives. Sutton will guide the day-to-day leadership of all information systems, while ensuring the appropriate alignment to enterprise cybersecurity and IT goals. Additionally, he will lead the HII enterprise cybersecurity and IT organizational and leadership change model to build high-performing teams. Sutton will report to Bharat Amin, HII’s executive vice president and chief information officer, for cybersecurity and IT-related activities and also will...

May 2021 Sales price Group sales prices development as follows Q1           2017       1,24 EUR/kg live weight (Jan 1,23 EUR – Feb 1,24 EUR – Marts 1,26 EUR) Q2           2017       1,41 EUR/kg live weight (Apr 1,43 EUR – May 1,41 EUR – June 1,39 EUR) Q3           2017       1,30 EUR/kg live weight (July 1,32 EUR – Aug 1,30 EUR – Sept 1,29 EUR) Q4           2017       1,13 EUR/kg live weight (Oct 1,17 EUR – Nov 1,12 EUR – Dec 1,11 EUR) Q1           2018       1,09 EUR/kg live weight (Jan 1,07 EUR – Feb 1,08 EUR – Marts 1,12 EUR) Q2           2018       1,17 EUR/kg live weight (April 1,18 EUR – May 1,15 EUR – June 1,18 EUR) Q3           2018       1,19 EUR/kg live weight (July 1,19 EUR, August 1,18 EUR, September 1,19) Q4           2018       1,10 EUR/kg live weight (Oct 1,11 EUR – Nov 1,12 EUR – Dec 1,07 EUR) Q1           2019      ...

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)         Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577   Date Total number of shares representing the share capital Total number of voting rights May, 31 2021 8 458 000 Gross total of voting rights : 12 768 717 Net total* of voting rights : 12 746 192   Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.               VIRBAC: Shaping the future of animal health NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP Corporate Finance: tel....

Dallas, Texas, June 18, 2021 (GLOBE NEWSWIRE) — World Series of Golf, Inc. (OTC Pink: WSGF) (“WSGF”) has launched a Peer to Peer (P2P), Fintech, Alternative Short-Term Rental Purchase Finance Application (App), called Vaycaychella. The Vaycaychella App currently includes the listing of 10 target new properties in Cuba to restore and make short-term vacation rental properties, expanding Vaycahychella’s pilot program.  The plan to finance the restoration of the 10 target properties is to offer a new cryptocurrency where holders of the cryptocurrency will be able to participate in the overall business surrounding the 10 target properties operation to include potential profit sharing. Vaycaychella allows anyone and everyone access to purchasing a short-term rental vacation property that can be listed on Airbnb, VRBO...

MINNEAPOLIS, June 18, 2021 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it has completed the closing of its previously announced registered direct offering of 15,520,911 shares of its common stock and warrants to purchase up to an aggregate of 15,520,911 shares of its common stock at a purchase price of $1.375 per share of common stock and related warrant in a registered direct offering priced at-the-market under Nasdaq rules. The warrants have an exercise price of $1.25 per share, will become exercisable upon the Company increasing its authorized capital stock to 200 million shares, and will expire three (3) years following the date the...

Notice is hereby given that the Management Board of AS Ekspress Grupp (registry code 10004677, official address Parda 6, 10151 Tallinn; hereinafter Ekspress Grupp) convenes the Extraordinary General Meeting of Shareholders, which will be held on 13 of July, 2021 at 10.00 at the seat of Ekspress Grupp, in the city of Tallinn, Parda 6, 6th floor. The registration of participants in the Meeting will commence at 9.30 at the location of the Meeting. The Management Board asks the shareholders to consider that due to the COVID-19 disease caused by the coronavirus it is advisable to minimize the extent of and participation in physical gatherings. Therefore, the Management Board urges the shareholders to vote on the draft resolutions prepared in respect to the items on the agenda of the general meeting using electronic means prior to the general...

Presentation to be part of the “Development of New Front Line Therapies to Prevent and Treat Non-SARS-CoV-2 Endemic Viral Diseases” Breakout Session WAKEFIELD, Mass., June 18, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announced that antiviral research related to Brilacidin has been accepted for an Oral Presentation at the 2021 Military Health System Research Symposium (MHSRS), taking place August 23-26, 2021, at the Gaylord Palms Resort and Convention Center, Kissimmee, FL. The MHSRS is an annual four-day scientific symposium sponsored by the U.S. Department of Defense. The presentation on Brilacidin will be part of the “Development of New Front Line Therapies to Prevent and Treat Non-SARS-CoV-2 Endemic Viral Diseases” Breakout Session. Out...

         European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis PARIS – June 18, 2021 – The European Commission (EC) has approved Aubagio® (teriflunomide) for the treatment of pediatric patients 10 to 17 years of age with relapsing-remitting multiple sclerosis (RRMS). The EC approval is based on data from the Phase 3 TERIKIDS study. The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European Union. MS affects an estimated 2.8 million people around the world, with children and adolescents representing at least 30,000 of those impacted.1,2 Pediatric MS is a rare condition and onset follows a relapsing-remitting...

In connection with the announced capital increase in Wirtek A/S (Company Announcement no. 10/2021) and pursuant to article 19 of EU-regulation 596/2014 (Market Abuse Regulation) E. I. Invest ApS has informed Wirtek that the company has purchased Wirtek shares maintaining a percentage of ownership above 10% of Wirtek A/S. After the purchases E. I. Invest ApS has a share of ownership of 10.13%. Attachment SM_12.2021_Transactions_Manager_18062021

Dallas, Texas, June 18, 2021 (GLOBE NEWSWIRE) — Alternet Systems, Inc. (OTC Pink: ALYI) today released a management update after conducting a scheduled review of its electric motorcycle development program last week with the dedicated design team from MODUS Applied Innovations.  The review and corresponding update include details on iQSTEL’s (OTCQB: IQST) contributions to ALYI’s electric motorcycle development program and EV Rideshare and Self-Drive Rental pilot program in Africa. The review and corresponding update also include details on a parallel electric motorcycle pilot recently initiated in Kenya by the United Nations. In summary, ALYI management is confident, after completing the review, that ALYI remains on track with its EV Rideshare and Self-Drive Rental pilot program in Africa.  ALYI EV Rideshare and Self-Drive Rental...